Luxembourg · Seed–Late Stage · 42 people tracked
Also known as EQT PARTNERS ASIA LIMITED · EQT Partners Japan K.K. · EQT REAL ESTATE, LLC
Find your way into EQT Life Sciences
2,882 people in our graph share verified history with the EQT Life Sciences team — schools, employers, funds. One of them is your warm intro.
Investment thesis
EQT Life Sciences targets innovative life sciences companies focused on therapeutics, medical devices, diagnostics and healthtech worldwide. It seeks the most innovative solutions to the greatest unmet clinical needs, backing scientists, clinicians and entrepreneurs with capital plus strategic, clinical, operational, financial and commercial support. The firm aims to transform cutting-edge scientific innovation into impactful healthcare solutions while striving for superior investor returns. With a 30-year track record, it has raised around 3.5 billion euros across 12 private funds and three investment strategies (Life Sciences Funds, Health Economic Funds, and a Dementia Fund).
Source: firm website, verified Aug 3, 2026.
Team · 42 people
from the firm's website & curated & public directories
What they invest in
from 42 of 45 portfolio companiesHealthtech ×30Biotech ×29Medical Devices ×24Deep Tech ×10AI & Machine Learning ×9Digital Health ×7Enterprise Software ×3Fintech ×2
HQs:United States×10Belgium×5Germany×3Netherlands×3Ireland×2Switzerland×1
Investments · 45 tracked
founders shown can be your intro pathBy year:2026 · 42025 · 52024 · 72023 · 62022 · 32021 · 22020 · 12019 · 129 dated
Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.
BiotechHealthtechMedical DevicesAntwerp, BE
Tim Knotnerus(Chief Executive Officer)in
Co-investorsAdBio partnersAndera PartnersAsabys PartnersCanaan PartnersPontifax Venture CapitalV-Bio Ventures+1 more
ATB Therapeutics is a biotech company developing bispecific antibody therapies and related immunological treatments.
BiotechHealthtechMedical Devices
Dr. Mark Throsby(Chief Executive Officer)
Co-investorsMRL Ventures FundV-Bio VenturesVIVES PartnersSambrinvestWallonie Entreprendre
Avidicure develops "Actibody", a triple-agonistic antibody platform built on a human IgG scaffold designed to activate the innate and adaptive immune system for treating oncology and autoimmune diseases.
AI & Machine LearningBiotech
Robert Friesen(Founder)in
Co-investorsBioGeneration VenturesBOMCurie CapitalKurma PartnersV-Bio Ventures
Egle Therapeutics develops targeted immunotherapy drugs by leveraging regulatory T cell (Treg) biology to treat autoimmune diseases and cancer.
Biotech
Fiorella Kotsias(Chief Scientific Officer)inBernard Vanhove(Chief Development Officer)in
BoardMichel Detheux(Chairman)in
Co-investorsFund+JDRF T1D Fund
ViCentra develops Kaleido, a compact and user-friendly insulin pump system for people with Type 1 diabetes.
Digital HealthHardwareMedical DevicesUtrecht, DE
Tim Oakes(CTO and Co-founder)
Co-investorsInnovation IndustriesInkef
Kinaset Therapeutics is a drug developer working on KN-002, a therapeutic candidate for treating severe asthma across patients regardless of the underlying cause of inflammation.
BiotechHealthtechMedfield, US
Roger Heerman(Chief Business/Operating Officer / Co-Founder)inFrazer Morgan(Chief Development Officer / Co-Founder)inRobert Clarke(Chief Executive Officer / Board Member / Co-Founder)Christopher O’Brien(Chief Medical Officer)
BoardJamil Beg(Director of the Issuer)inTom King(Director of the Issuer)
Co-investors5AM VenturesAtlas VentureRA CapitalSixty Degree CapitalVivo CapitalGimv+3 more
MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.
BiotechHealthtech
PerBengt(CSO)
Co-investorsAdjuvant CapitalIndustrifondenOrbiMedPureos BioventuresSanofi VenturesSunstone Capital+2 more
Sequana Medical develops the alfapump system and DSR therapy for treating fluid overload in patients with conditions such as liver disease and heart failure.
BiotechHealthtechMedical DevicesGhent, BE
Co-investorsNewton BiocapitalBlackRockKreos CapitalRosetta Capital Ltd.VI PartnersBootstrap Europe+2 more
T-knife Therapeutics is a biopharmaceutical company developing T cell therapies to treat cancer, with an initial focus on solid tumors.
BiotechHealthtechBerlin, DE
Elisa Kieback(Co-founder & Chief Technology Officer)inThomas Blankenstein(Scientific Founder)Thomas Soloway(Chief Executive Officer)Camille Landis(Chief Business Officer / Chief Financial Officer)inPeggy Sotiropoulou(Chief Scientific Officer)in
Co-investorsAndera PartnersVersant VenturesRA CapitalSixty Degree CapitalFidelity Investments
VarmX develops VMX-C001, a therapeutic medicine for treating severe bleeding in patients on Factor Xa anticoagulants and for emergency surgery settings.
BiotechHealthtechMedical Devices
Pieter ReitsmainJohn Glasspool(Chief Executive Officer)in
Co-investorsSound BioventuresYsios CapitalBioGeneration VenturesEICInkefUNIIQ+2 more
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Luc Dochez(Chair and Founder)inJosh Mandel-Brehm(Co-Founder)in
Co-investorsDroia VenturesKurma PartnersPureos BioventuresSeroba Life SciencesEurazeoIdinvest Partners+1 more
Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.
BiotechHealthtechPalo Alto, US
Luis Pena(Executive Officer, Director)inJanice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)
Board seatFelice Verduyn - Van Weegen· per SEC Form D · $115.5M raise · filed Jan 2025
Co-investorsAndera PartnersAvego BioScience CapitalB Capital GroupB4 CapitalBeiersdorf Innovation FundFemHealth Ventures+3 more
.jpeg){kind=logo}
Lumeon provides an automated care orchestration platform that pulls data from health systems' care processes and existing systems and applies clinical intelligence to coordinate individualized patient care.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechBoston, US
Robbie Hughes(CEO and Founder)in
Board seatRudy Dekeyser· per SEC Form D · $12M raise · filed Aug 2023
Co-investorsEndeavour VisionOptum VenturesTechstarsAmadeus Capital Partners
1X is an AI and robotics company developing general-purpose humanoid robots for home and industrial use.
AI & Machine LearningConsumerHardwareRoboticsPalo Alto, US
Bernt Øyvind Børnich(CEO)inBernt Børnich(Founder)in
Co-investorsAccess Ventures (New York)Alliance VCAlliance VentureEQT VenturesSamsung NextSandwater+9 more
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.
BiotechDeep TechHealthtechMedical Devices
Stuart Milstein(Co-Founder)inJack O’Meara(Cofounder)in
Co-investorsage1BackedBlueYard CapitalEntrepreneur FirstIaso VenturesPsyMed Ventures+4 more
Co-investorsAndera PartnersCTI Life Sciences Fund L.P.Kurma PartnersLSP (Life Sciences Partners)Sofinnova Partners
Artios develops DNA damage response (DDR)-based medicines targeting patients with high unmet need cancers.
BiotechHealthtechMedical Devices
Co-investorsAndera PartnersM VenturesNovartis Venture FundPfizer Venture InvestmentsRA CapitalSofinnova Partners+2 more
Biotech
Co-investorsKurma PartnersSofinnova PartnersJohnson & Johnson Innovation – JJDCM VenturesSR One Capital Management
Atalanta is developing treatment options for intractable central nervous system diseases using RNA interference technology.
BiotechDeep TechHealthtechMedical Devices
Co-investorsF-Prime CapitalNovartis Venture FundRiverVest Venture PartnersSanofi Venturesabrdn plc
Cambridge Vision Technology develops diagnostic hardware and software for detecting Alzheimer's disease and other neurodegenerative conditions through retinal imaging and biomarker analysis.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCambridge, US
Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.
BiotechDeep TechMedical DevicesNiel, BE
Co-investorsFund+PMVBoehringer Ingelheim Venture FundNovalis LifeSciencesPWV
Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.
HealthtechMedical Devices
Co-investorsAtlantic Bridge VenturesClaret Capital PartnersMVM Life Science PartnersEnterprise IrelandFountain Healthcare PartnersSofinnova Partners+1 more
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device that delivers patient-controlled electrical stimulation to treat chronic post-amputation pain in adult lower limb amputees.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President and CEO)Zach Stassen(Chief Financial Officer)Robert J. Centa(Chief Financial Officer)Jon J. Snyder(Director, President, Secretary and CEO)in
BoardJoyce Erony(Director)inWilliam Harrington(Director)
Co-investorsAmzak HealthAPERTURE Venture PartnersCWRU Technology VenturesiSelect FundJobsOhio VenturesJumpstart Ventures+6 more
NewAmsterdam Pharma develops innovative therapies for cardiovascular disease and lipid-related conditions.
BiotechHealthtechMedical Devices
Co-investorsBain Capital Life SciencesFrazier Life SciencesLSP (Life Sciences Partners)Forbion
Nobi manufactures intelligent lamps equipped with optical sensors and artificial intelligence to detect falls and monitor health for elderly care in residential facilities and home settings.
AI & Machine LearningHealthtechIoT
Roeland Pelgrims(Founder)in
Co-investors15th RockAngelini VenturesPMV
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.
BiotechHealthtechMedical Devices
Ilise Lombardo(Chief Executive Officer)inVolker Knappertz(Executive Vice President of Research & Development)inMichael Samar(Chief Financial Officer)inRob Lasser(Chief Medical Officer)in
Co-investorsBioMedPartnersJeito CapitalRoche Venture FundSofinnova PartnersEQTForbion+2 more
NUA Surgical develops surgical medical devices focused on maternal and infant health, currently in pre-clinical development.
FemTechHealthtechMedical DevicesGalway, IE
Barry(CEO & Founder)inMarie Therese(COO & Co-Founder)inPadraig(CTO & Co-Founder)
Co-investorsTMC Venture FundEnterprise Ireland
Onera Health provides clinical-grade remote diagnostics and monitoring solutions for healthcare professionals, with an initial focus on sleep health.
Digital HealthHealthtechMedical DevicesEindhoven, NL
Co-investors15th RockLSP (Life Sciences Partners)imec.xpandInnovation Industries
PanTera develops actinium-225, a therapeutic radioisotope used in precision cancer treatment through radiotheranostics, serving oncology patients and pharmaceutical companies globally.
BiotechDeep TechHealthtechMedical DevicesMol, BE
Sven van den berghe(CEO)inChristophe Malice(CBO)inSamy Bertrand(CTO)inYves Sterckx(Director of Finance & Administration)inPhilippe Vanwolleghem(Director Quality, Regulatory Affairs & HSE)
Co-investorsKorysKurma PartnersLSP (Life Sciences Partners)PMV
Payrails provides a modular financial operating system for enterprises that manages payment and financial workflows.
Enterprise SoftwareFintechSaaSBerlin, DE
Emre Talay(Founder)inNicolas Thouzeau(Founder)inOrkhan Abdullayev(Founder)in
Co-investorsAndreessen HorowitzDeBa VenturesEQT VenturesGeneral CatalystHV Capital
.png)
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy.
Deep TechHealthtechMedical DevicesGalway City, IE
Wayne Allen(Co-Founder, CEO, Director)inLiam Mullins(CTO and Co-founder)in
Co-investorsSeroba Life SciencesSV Health InvestorsEnterprise Ireland
Phagenesis develops targeted pharyngeal electrical stimulation technology to treat neurogenic dysphagia by restoring neural pathways for safe swallowing.
Deep TechDigital HealthHealthtechMedical Devices
Co-investorsAphelion CapitalInnvotec Ltd.Northern GritstoneSectoral Asset Management
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms.
BiotechDeep TechMedical DevicesCambridge, US
Kevin Eggan(Co-founder)inRoet(Co-founder)Woolf(Co-founder)Kasper Roet(Director, Executive Officer, Promoter)inShafique Virani(Executive Officer)inJason Brown(Mr. Brown is the Chief Financial Officer of the Issuer.)in
Co-investorsDroia VenturesMC Healthcare VenturesMission BiocapitalMitsui Global InvestmentSanofi VenturesSV Health Investors+7 more
RQ Bio discovers and develops long-acting monoclonal antibodies (LAAbs) targeting seasonal influenza to provide protection against severe viral disease.
BiotechHealthtech
Co-investorsFrazier Life SciencesLifeArc VenturesForbionOxford Science EnterprisesRed Tree VentureWellington Management
Sana is an AI lab that develops agentic AI systems to help teams access knowledge, automate repetitive work, and learn.
AI & Machine LearningEnterprise SoftwareFuture of WorkStockholm, SE
Co-investorsAcequia Capital (AceCap)EQT VenturesLeksell Social VenturesMenlo VenturesNew Enterprise Associates (NEA)Workday Ventures
Shinobi develops next-generation cell therapies using iPSC (induced pluripotent stem cell) research, genetic engineering, and clinical infrastructure.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsAstellas Venture Management LLCF-Prime CapitalFast Track InitiativeJIC Venture Growth InvestmentsKyoto University Innovation Capital
SpliceBio develops genetic medicines using a proprietary protein splicing platform to treat diseases caused by mutations in large genes.
BiotechDeep TechDigital HealthBarcelona, ES
Dr. Vila-Perelló(CEO)Dr. Frutos(Co-founder)
Co-investorsNovartis Venture FundRoche Venture FundSanofi VenturesYsios CapitalAsabys PartnersCriteria Bio Ventures+3 more
Vaderis develops a first-of-its-kind oral therapy for hereditary hemorrhagic telangiectasia (HHT), a rare vascular disease with no existing approved treatments.
BiotechHealthtechMedical Devices
Co-investorsDroia VenturesMedicxiGoldman Sachs
VICO provides AI-generated forecasts and event risk ratings that track and triangulate analyst views into continuous time series data.
AI & Machine LearningData & InfrastructureFintech
Co-investorsAIN VenturesMultiball CapitalDroia VenturesEurazeoKurma PartnersPureos Bioventures
The World Health Organization is a United Nations agency founded in 1948 that leads global health initiatives and emergency response across 194 member states.
Digital HealthGovTechHealthtech
Co-investorsatai Life SciencesAtaiBeckleyICONIQMaRS
Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology.
BiotechDeep TechHealthtechMedical Devices
Eliane Schutte(Chief Executive Officer)in
Co-investorsKurma PartnersVI PartnersYsios CapitalAmadeus Capital PartnersInvest-NL
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Kiadis Pharma N.VEgle TherapeuticsNeuraviXilis, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
1 acquisitionsNeuraviacq. by Johnson & Johnson
Portfolio news
latest coverage across their companies
Vaderis Therapeutics · fiercebiotech.com · Sep 9, 2026
Agomab Therapeutics · investing.com · Aug 10, 2026
Xeltis · med-techinsights.com · Aug 6, 2026
Evommune · stocktitan.net · Aug 6, 2026
RQ Bio · fundraiseinsider.com · Jun 29, 2026
Quralis · nasdaqprivatemarket.com · Apr 3, 2026
Neurent Medical · mondaq.com · Feb 26, 2026
Frequently asked questions
- How many investments has EQT Life Sciences made?
- EQT Life Sciences has 45 tracked investments, 1 of which have exited, including 12 dated in the last 24 months.
- What stage does EQT Life Sciences invest at?
- EQT Life Sciences invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is EQT Life Sciences's typical check size?
- EQT Life Sciences typically writes checks of $11M – $66M.
- What sectors does EQT Life Sciences focus on?
- EQT Life Sciences focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices, Sector Agnostic.
- Where is EQT Life Sciences located?
- EQT Life Sciences is headquartered in Luxembourg, LU.
- Does EQT Life Sciences lead rounds?
- Yes, EQT Life Sciences leads investment rounds.
- Who does EQT Life Sciences co-invest with?
- EQT Life Sciences most often shares deals with LSP (Life Sciences Partners), 15th Rock, Kurma Partners, among 15 tracked co-investors.
Media · Podcasts & interviews
from their channelEQT Value Creation Day in London 2026
EQT
EQT AB Annual Shareholders' Meeting 2026
EQT
Per Franzen and Jean Eric Salata on CNBC's Squawk Box Asia
EQT
India's Investment Journey with Hari Gopalakrishnan
EQT
How Being an “Outsider” Could Give You an Inside Advantage
EQT
Stop Trying to Be Like Everyone Else, Says Our Founder
EQT
Co-investors · 49
Kurma Partners is a European healthcare-focused investment firm that co-founds and finances biotech and healthcare companies, working closely with research centers to translate scientific discoveries into high-tech companies.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Andera Partners is an asset management firm specializing in private equity that partners with companies and their management to support sustainable growth. It has backed 377 companies over more than 20 years.
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in early-stage biotech and digital health companies focused on improving human health. It serves as Sanofi's entry point into the innovation ecosystem.
Forbion is a global venture capital firm focused on advancing biotech innovations and sustainable solutions aimed at improving human and planetary health.
The Novartis Venture Fund invests in innovative life science companies, focusing on biotechnology and biopharmaceuticals at various stages of growth, aiming to drive patient benefit and generate returns.
Ysios Capital is a life sciences investor that finances innovative biotech companies worldwide, providing resources to develop novel therapies for indications with high unmet medical needs.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
F-Prime Capital is an early-stage-focused investment firm backing companies across life sciences, technology, healthtech and services, and crypto.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
Seroba is a Dublin-based life sciences venture capital firm investing in early-stage biotech and medtech companies developing new therapeutics and medical devices.
▶37 more co-investors
MC Healthcare VenturesCanaan PartnersAtlas VentureUS Venture PartnersOrbiMedOUP (Osage University Partners)Versant VenturesSR One Capital Management5AM VenturesAtlantic Bridge VenturesPfizer Venture InvestmentsPivotal Life SciencesPontifax Venture CapitalCatalio Capital ManagementMission BiocapitalBioqube VenturesAPERTURE Venture PartnersSignet Healthcare PartnersFounder CollectivePlug and Play VenturesBalderton CapitalCreandumAntlerARCH Venture PartnersEarlybird Venture CapitalXtripe AngelsAbingworthIterative Instinct CapitalBusiness Growth FundAdvent Life SciencesVantagePoint Capital PartnersSamsara BioCapitalIllumina VenturesCasdin CapitalTheVentureCityPappas CapitalStanley Ventures
Firms observed investing alongside EQT Life Sciences, from public investor directories. Shared companies are the overlap with EQT Life Sciences's recorded portfolio.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.
Blackstone Life Sciences (BXLS) is Blackstone's life sciences investment arm that designs, funds and executes clinical trials to advance late-stage pharmaceutical, biotech and medical technology products to market.